RBM38
History
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2019-12-10 : Wienand : PMBL
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 2 | relevance in PMBL/cHL/GZL not firmly established1 |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
| Entity | source | frequency (%) |
|---|---|---|
| BL | GAMBL Exome | 2.299 |
| BL | GAMBL Genome | 0.386 |
| DLBCL | GAMBL Exome | 2.049 |
| DLBCL | GAMBL Genome | 3.383 |
| FL | GAMBL Exome | 2.006 |
| MCL | GAMBL Genome | 0.585 |
References
1.
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu
D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A,
Heubeck AT, Buonopane MJ, Redd RA, Bojarczuk K, Lawton LN, Armand P,
Rodig SJ, Fromm JR, Getz G, Shipp MA. Genomic analyses of flow-sorted
Hodgkin Reed-Sternberg cells reveal complementary
mechanisms of immune evasion. Blood Adv. 2019 Dec 10;3(23):4065–4080.
PMCID: PMC6963251

